PCI Biotech Holding ASA 4QG.F Stock
PCI Biotech Holding ASA Price Chart
PCI Biotech Holding ASA 4QG.F Financial and Trading Overview
| PCI Biotech Holding ASA stock price | 0.17 EUR |
| Previous Close | 0.17 EUR |
| Open | 0.15 EUR |
| Bid | 0.16 EUR x N/A |
| Ask | 0.18 EUR x N/A |
| Day's Range | 0.15 - 0.15 EUR |
| 52 Week Range | 0.09 - 0.32 EUR |
| Volume | 3.5K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 6.01M EUR |
| Beta (5Y Monthly) | 1.629 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4QG.F Valuation Measures
| Enterprise Value | -38705304 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.1523159 |
| Price/Book (mrq) | 0.122673035 |
| Enterprise Value/Revenue | -13.863 |
| Enterprise Value/EBITDA | 1.058 |
Trading Information
PCI Biotech Holding ASA Stock Price History
| Beta (5Y Monthly) | 1.629 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.32 EUR |
| 52 Week Low | 0.09 EUR |
| 50-Day Moving Average | 0.16 EUR |
| 200-Day Moving Average | 0.15 EUR |
4QG.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 37.33M |
| Float | 29.47M |
| Short Ratio | N/A |
| % Held by Insiders | 27.39% |
| % Held by Institutions | 9.10% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3418.91% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -26.33% |
| Return on Equity (ttm) | -47.53% |
Income Statement
| Revenue (ttm) | 2.79M EUR |
| Revenue Per Share (ttm) | 0.08 EUR |
| Quarterly Revenue Growth (yoy) | -84.39% |
| Gross Profit (ttm) | 4.75M EUR |
| EBITDA | -36600000 EUR |
| Net Income Avi to Common (ttm) | -29197000 EUR |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 45.58M EUR |
| Total Cash Per Share (mrq) | 1.22 EUR |
| Total Debt (mrq) | 572K EUR |
| Total Debt/Equity (mrq) | 1.22 EUR |
| Current Ratio (mrq) | 9.687 |
| Book Value Per Share (mrq) | 1.257 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -30126000 EUR |
| Levered Free Cash Flow (ttm) | -26032750 EUR |
Profile of PCI Biotech Holding ASA
| Country | Germany |
| State | N/A |
| City | Oslo |
| Address | UllernchaussEen 64 |
| ZIP | 0379 |
| Phone | 47 67 11 54 00 |
| Website | https://www.pcibiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.
Q&A For PCI Biotech Holding ASA Stock
What is a current 4QG.F stock price?
PCI Biotech Holding ASA 4QG.F stock price today per share is 0.17 EUR.
How to purchase PCI Biotech Holding ASA stock?
You can buy 4QG.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PCI Biotech Holding ASA?
The stock symbol or ticker of PCI Biotech Holding ASA is 4QG.F.
Which industry does the PCI Biotech Holding ASA company belong to?
The PCI Biotech Holding ASA industry is Biotechnology.
How many shares does PCI Biotech Holding ASA have in circulation?
The max supply of PCI Biotech Holding ASA shares is 37.49M.
What is PCI Biotech Holding ASA Price to Earnings Ratio (PE Ratio)?
PCI Biotech Holding ASA PE Ratio is now.
What was PCI Biotech Holding ASA earnings per share over the trailing 12 months (TTM)?
PCI Biotech Holding ASA EPS is -0.05 EUR over the trailing 12 months.
Which sector does the PCI Biotech Holding ASA company belong to?
The PCI Biotech Holding ASA sector is Healthcare.